Clinical Trial Update: Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating CimetrA in patients diagnosed with COVID-19 has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease

Drugs mentioned

• CimetrA

Snippet

Sponsor: MGC Pharmaceuticals d.o.o | Conditions: Covid19, Corona Virus Infection | Phase 2 | Status: COMPLETED